Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade

SIMPLE SUMMARY: Tumor cells can evade destruction via immune cells by expressing coinhibitory membrane molecules, which can suppress tumor-specific T cells. Immune checkpoint inhibitor therapies act by blocking these inhibitory pathways via monoclonal antibodies. Although this type of immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Möller, Miriam, Turzer, Steffi, Ganchev, Georgi, Wienke, Andreas, Schütte, Wolfgang, Seliger, Barbara, Riemann, Dagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367406/
https://www.ncbi.nlm.nih.gov/pubmed/35954354
http://dx.doi.org/10.3390/cancers14153690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367406/
https://www.ncbi.nlm.nih.gov/pubmed/35954354
http://dx.doi.org/10.3390/cancers14153690

Ejemplares similares